| | | Autoimmune | Sarcoidosis
 | At least two cases of sarcoidosis have been successfully treated with 20mg of melatonin per day.These were chronic sarcoidosis cases unresponsive to long-term steroidal therapy.[The Lancet November 4, Vol 346, pp.1229-1230, 1995] |
|
Circulation |
Hypertension
 | Researchers discovered that if men take melatonin before bedtime, their blood pressure may decrease as much as if they were taking a antihypertensive drug. The participants in the study took 2.5mg of melatonin for a three week period. As expected, melatonin also increased their quality and quantity of sleep. [Hypertension. 2004 Feb;43(2): pp.192-7]
The authors of this study caution that melatonin should not be used for treating hypertension based on this single trial, and that more studies are required. |
|
Environment / Toxicity |
Heavy Metal Toxicity
Not recommended for:
Seasonal Affective Disorder (SAD)
 | Although it cannot be established that SAD is caused by abnormal melatonin metabolism, in some people melatonin makes the symptoms of SAD worse (Tarquini et al. 1998). These people should stop melatonin or reduce its dosage during the times of the year when darkness appears early in the day. |
|
Hormones |
Low Melatonin Level
Night Eating Syndrome
|
Mental | Not recommended for:
Tendency Toward Postpartum Depression
 | On the basis of theoretical ideas about how melatonin works, some authorities specifically recommend against using it for depression, schizophrenia, autoimmune diseases and other serious illnesses, and in pregnant or nursing women. |
|
Metabolic |
Insomnia
 | The body uses the hormone melatonin as part of its normal control of the sleep-wake cycle: melatonin plays an important role in the induction of sleep. The pineal gland - a tiny gland at the base of the brain - makes serotonin and then turns it into melatonin when light decreases. Strong light (such as sunlight) turns off melatonin production. Completely darkened rooms increase melatonin levels more than partially darkened rooms, and weak light doesn't completely shut down melatonin production as does strong light.
Taking melatonin as a supplement seems to stimulate sleep when the natural cycle is disturbed. It has been used for jet lag and for those who work night shifts and want to change their hours of sleep on the weekends.
Sustained-release melatonin may provide sleep enhancement for those who have difficulty remaining asleep. Several double-blind trials show melatonin supplementation to be very effective in promoting sleep. However, it appears that the sleep-promoting effects of melatonin supplementation are most apparent if an individual's melatonin levels are low. Melatonin supplementation does not act as a simple sedative like a sleeping pill; only if this sleep-producing hormone is deficient will supplementation be helpful. Furthermore, melatonin acts to regulate or alter sleep rhythms, so its effect may be stronger with problems getting to sleep initially than with sleep disturbances once asleep.
One double-blind study enrolled 320 people who were given 5mg of standard melatonin, 5mg of slow-release melatonin, 0.5mg of standard melatonin, or a placebo for 4 nights following plane travel. The results showed improvements only with 5mg of standard melatonin. Benefits were noted in time to fall asleep, quality of sleep, and daytime drowsiness and fatigue. Positive results were seen in several other studies but at least one study failed to find a significant sleep-inducing effect for melatonin. On balance, the evidence is strongly positive that melatonin can help sleep.
According to one review of the literature, treatment is most effective for those with significant jet lag, such as those who have crossed more than 8 time zones. However, melatonin also seems to be help induce sleep for other people, including those with no sleep problems to begin with.
One week of supplementation with melatonin (0.1mg, 0.3mg, or 3mg before bedtime) in 30 patients with insomnia over 50 years old with reduced melatonin levels, improved sleep in a double-blind, placebo-controlled, cross-over study. The 3mg per day dose induced hypothermia and caused plasma melatonin to remain elevated into the daylight hours. [ J Clin Endocrinol Metab 2001;86(10): pp.4727-4730]
One week of treatment with melatonin, either 0.1mg or 0.3mg given 30 minutes before bedtime, did improve sleep in a well controlled cross-over study in Austria of 20 patients with mental retardation and sleep deficits. [J Autism Dev Disorders 2003;33(4): pp.469-72] |
Headaches, Cluster
 | A drop in nocturnal melatonin has been linked with cluster headaches, and melatonin supplementation has shown a low but significant preventive capacity for cluster headaches. In a blinded trial, 10mg of melatonin was given to 10 subjects and a placebo was given to 10 controls for 14 days. 5 out of 10 treated patients reported a decline in attack frequency after 3-5 days of treatment and then experienced no further attacks until melatonin was discontinued. The melatonin was taken in a single evening dose. [Cephalalgia. 1996;16: pp.494-496] |
Headaches, Migraine/Tension
 | Three cases of idiopathic stabbing headache were reported in which melatonin (3 to 12mg at bedtime) was used successfully in their treatment. [Neurology 2003;61(6): pp.865-6] |
Not recommended for:
Male Gynecomastia
 | One case of painful gynecomastia has been reported involving a 56 year old man who had been suffering from amyotrophic lateral sclerosis and was taking 1 to 2mg melatonin per day over a 1 1/2 year period. As the gynecomastia disappeared after melatonin use was discontinued, it was suspected that the melatonin caused this side effect. |
|
Nervous System |
Seizure Disorder
 | In a preliminary study, 6 children with severe intractable seizures were given a 3mg tablet of melatonin 30 minutes before bedtime in addition to their usual anti-seizure medication for three months. A reduction in seizure activity, particularly during the night, was experienced by 5 out of 6 starting 3 days after treatment began. The mean seizure rate decreased from 3.6 per day to 1.5 per day. According to the parents, daytime behavior also improved. This therapy should be monitored closely as a previous study with melatonin found increased seizure activity in some children. [Epilepsia 2001;42: pp.1208-10] |
Tardive Dyskinesia
 | A double-blind study demonstrated that 10mg of melatonin given at 8pm for 6 weeks is an effective treatment for tardive dyskinesia, although the magnitude of the effect was only modest. Other natural substances that have been reported to improve tardive dyskinesia include vitamin E, manganese and vitamin B6. It is possible that using these compounds in combination would be more effective than using any one individually. [Arch Gen Psychiatry 2001;58: pp.1049-52] |
|
Risks |
Cancer / Risk - General Measures
 | Melatonin has been shown to inhibit several types of cancer, especially hormone-related cancers like breast cancer and prostate cancer. This may be due to its ability to reduce the number of cellular estrogen receptors, which reduces the production of cell-multiplication factors. The immune-modulating properties of melatonin seem to convey additional anti-cancer properties. It has been shown to support the use of interleukin-2 in anti-cancer therapy, especially under conditions of controlled lighting. Many animal studies have demonstrated an increase in tumor growth rates in animals whose pineal glands have been removed.
Various researchers report successes against solid tumors, colorectal cancer, non-small cell lung cancer, brain metastases, glioblastoma, estrogen receptor-negative breast cancer, prostate cancer, metastatic renal cancer and adenocarcinoma of the pancreas. Furthermore, these effects seem to be substantial.
To select a typical example, people with solid tumors were given either just IL-2 (a regulator of the immune system), or IL-2 plus melatonin. 15% of the people receiving just IL-2 survived after one year, whereas 46% of the people also receiving melatonin survived. One researcher reported no failures i.e. instances in which melatonin did not have a positive effect. It has been proposed that melatonin might be useful for treating the general ill health found in cancer. |
Increased Risk of Alzheimer's / Dementia
 | Ensure normal melatonin levels. Melatonin, a powerful antioxidant and heavy-metal-chelating agent, has been shown to protect against heavy metal exposure which is in turn implicated in Alzheimer's Disease.
After exposing nerve cells to inorganic mercury, neurobiologists observed a toxic reaction that reduced cellular levels of the antioxidant glutathione by 30%, triggered the release of plaque-forming ß-amyloid peptides, and spurred the hyperphosphorylation of tau-protein - all pivotal mechanisms in the development and progression of Alzheimer's.
However, they found that if the cells were first incubated with melatonin - a powerful antioxidant and heavy-metal-chelating agent - they were protected from these damaging effects. In fact, despite being exposed to toxic doses of mercury, the cells treated with melatonin often showed metabolic status comparable to that of mercury-free cells.
These results provide strong experimental evidence that mercury toxicity may be involved in Alzheimer's development and that melatonin shows a marked potential to neutralize this toxic-induced pathology, by boosting antioxidant defense and binding to heavy metals. |
|
Tumors, Malignant |
Prostate Cancer
 | Melatonin has been shown to inhibit several types of cancers, especially hormone-related cancers like breast cancer and prostate cancer. [Bartsch and Bartsch] This may be due to its ability to reduce the number of cellular estrogen receptors, which reduces the production of cell-multiplication factors. The immune-modulating properties of melatonin seem to convey additional anti-cancer properties. It has been shown to support the use of interleukin-2 in anti-cancer therapy, especially under conditions of controlled lighting. Many animal studies have demonstrated an increase in tumor growth rates in animals whose pineal glands have been removed.
Positive results have been shown with melatonin on its own and in combination with interferon, tumor necrosis factor, and tamoxifen. These preliminary results are quite encouraging because approximately 30 percent of the patients taking anywhere from 10 to 50 milligrams daily (at 8pm) experienced improvements in survival time and quality-of-life assessments. (Lissoni et al, Brit J Cancer 7l(4): pp.854-56, 1995) |
|
Uro-Genital | Not recommended for:
Possible Pregnancy-Related Issues
 | On the basis of theoretical ideas about how melatonin works, some authorities specifically recommend against using it for depression, schizophrenia, autoimmune diseases and other serious illnesses, and in pregnant or nursing women. |
Motherhood Issues
 | On the basis of theoretical ideas about how melatonin works, some authorities specifically recommend against using it for depression, schizophrenia, autoimmune diseases and other serious illnesses, and in pregnant or nursing women. |
|
| |